In fibrodysplasia ossificans progressive (FOP), a special type of genetic HO, TGF-β has been shown to play an important role that the pharmacologic inhibition of TGF-β signaling decreases osteogenic differentiation of FOP fibroblasts [3]. Here, TGFB1 is linked to fibrodysplasia ossificans progressiva.